Biotech | February 17, 2022
PerkinElmer’s SIRION Biotech and CRG to develop diabetes gene therapy
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Two out of three people under the age of 40 are at risk of prediabetes
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The start-up has announced the scheme to mark World Diabetes Day
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
The company claims that its Empagliflozin tablets are the most affordable in India
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
Subscribe To Our Newsletter & Stay Updated
